Anavex President & CEO Christopher U. Missling, PhD, to Participate in a Roundtable Discussion
- ANAVEX® Life Sciences Corp.
- Apr 21, 2017
- 1 min read
Anavex President & CEO Christopher U. Missling, PhD, to participate in a roundtable discussion at the World Orphan Drug Congress USA, Friday, at 12:20 PM on April 21.
Wardmar Park Marriott Washington, DC
Roundtable 4: Partnerships- successful collaboration between a rare disease foundation and a pharmaceutical company to advance preclinical and clinical research in Rett Syndrome.